Spectral Medical Inc. logo

Spectral Medical Inc. (EDTXF)

Market Open
11 Dec, 20:00
OTC PINK OTC PINK
$
0. 95
0
0%
$
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-0.04 Eps
$ 0.95
Previous Close
Day Range
0.95 0.95
Year Range
0.32 1.31
Want to track EDTXF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

EDTXF trading today higher at $0.95, an increase of 0% from yesterday's close, completing a monthly decrease of -10.38% or $0.11. Over the past 12 months, EDTXF stock gained 173.78%.
EDTXF is not paying dividends to its shareholders.
The last earnings report, released on Nov 07, 2025, missed the consensus estimates by -0.07%. On average, the company has fell short of earnings expectations by -0.03%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on TSX (CAD).

EDTXF Chart

Spectral Medical Inc. (EDTXF) FAQ

What is the stock price today?

The current price is $0.95.

On which exchange is it traded?

Spectral Medical Inc. is listed on TSX.

What is its stock symbol?

The ticker symbol is EDTXF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

Has Spectral Medical Inc. ever had a stock split?

No, there has never been a stock split.

Spectral Medical Inc. Profile

Professional Services Industry
Industrials Sector
Mr. Christopher Seto CEO
OTC PINK Exchange
CA8475771033 ISIN
CA Country
29 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Spectral Medical Inc. is a pioneer in the development and commercialization of innovative treatment solutions for septic shock, with its operations extending across the United States, Italy, Ireland, and other international markets. Established in 1991 and originally known as Spectral Diagnostics Inc., the company underwent a name change to Spectral Medical Inc. in December 2014, reflecting a broader focus on medical solutions beyond diagnostics. Headquartered in Toronto, Canada, Spectral Medical Inc. is dedicated to combating septic shock, a serious medical condition that poses significant treatment challenges worldwide.

Products and Services

  • Endotoxin Activity Assay

    A unique diagnostic tool, the Endotoxin Activity Assay (EAA) serves as a rapid in vitro test designed to detect components of the gram-negative bacterial cell wall. By identifying the presence of endotoxins, which are often a precursor to septic shock, this assay allows healthcare providers to rapidly diagnose and initiate treatment, potentially saving lives through early intervention.

  • Polymyxin B Hemoperfusion

    This therapeutic device represents a significant advancement in the treatment of septic shock. Through the process of hemoperfusion, it effectively removes endotoxins from the bloodstream. By directly addressing the source of the problem, Polymyxin B Hemoperfusion has the potential to significantly improve patient outcomes in cases of severe infection.

  • Biological Components Development

    Spectral Medical Inc. not only delivers finished medical devices but also focuses on the development and manufacturing of key biological components that play a crucial role in the medical diagnostics field. This includes the creation of monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators. These components are essential for research and development within the medical community, as well as for the production of diagnostics by other companies in the industry. Through this multifaceted approach, Spectral Medical Inc. contributes widely to advancements in diagnostic technologies and treatments.

Contact Information

Address: 135 The West Mall, Toronto, ON, Canada, M9C 1C2
Phone: 416-626-3233